FrontierLab
A research filter, not a predictor — not financial advice. Grades rank growth stocks on evidence-based quality signals from end-of-day data; they are not buy/sell calls or price forecasts. Always do your own research.

Enovis Corporation ENOV

Mixed   broader-coverage candidate · Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices.

On FrontierLab's discovery record since 2026-07-27 (3 weeks ago) — when this name first surfaced. (distinct from the snapshot date below)

Auto-graded broader coverage — sourced by an automated screen and graded on default bands, not the sector-calibrated bands the curated screener uses. A "Mixed" here is NOT the same bar as a curated grade; these are auto-screened candidates for your own research, shown as of their surface date (2026-07-28), not the curated Frontier signal.
Pump risk: parabolic/spike characteristics detected in the screen flags. Treat any positive grade with extra skepticism.

Key quality signals

Revenue growth (YoY)6%
Gross margin56.8%
Gross profits / assets0.34
Rule of 408.7
Net margin2.7%
Cash runway (months)
PEG
Price / sales0.7

Quality checklist

Fundamentals — snapshot as of 2026-07-28

StageEstablished
Share issuance (YoY)0% · flat share count
Moat
TAM
P/E (trailing)
EPS (trailing)$-20.02
Burn multiple
Gross-margin trend (pts)0.3
Cash / assets0.01
Net debt / EBITDA
Statements as ofQ1 FY2026 · filed 2026-05-07

Momentum context — a snapshot from 2026-07-28, not current

Price at surface$28.25 (as of 2026-07-28)
52-week range$19.14 – $34.28
% off 52-wk high-17.6%
RSI (14)62
Relative volume0.6×

Risk flags

Parabolic one-day spike (+15%) in the last month — extreme single-day moves tend to mean-revert.

← All broader-coverage names · Curated names → · Open the interactive screener →

Data as of 2026-07-28 (end-of-day). How grades are computed →